Breaking News Instant updates and real-time market news.

MBIO

Mustang Bio

$7.32

0.08 (1.11%)

, FBIO

Fortress Biotech

$2.70

-0.105 (-3.75%)

08:36
07/19/18
07/19
08:36
07/19/18
08:36

Mustang Bio completes pre-IND meeting with FDA for MB-102

Mustang Bio (MBIO), a Fortress Biotech (FBIO) company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell, or CAR T, technology, announced today that it has completed a pre-Investigational New Drug, or pre-IND, meeting with the FDA for MB-102. MB-102 is a CAR T therapy in development for the treatment of acute myeloid leukemia, or AML, blastic plasmacytoid dendritic cell neoplasm, or BPDCN, and high-risk myelodysplastic syndrome, or MDS. Mustang will continue its efforts on its IND filing to the FDA for MB-102.

MBIO

Mustang Bio

$7.32

0.08 (1.11%)

FBIO

Fortress Biotech

$2.70

-0.105 (-3.75%)

MBIO Mustang Bio
$7.32

0.08 (1.11%)

12/20/17
OPCO
12/20/17
INITIATION
Target $18
OPCO
Outperform
Mustang Bio initiated with an Outperform at Oppenheimer
Oppenheimer started Mustang Bio with an Outperform rating and $18 price target.
12/21/17
OPCO
12/21/17
INITIATION
Target $18
OPCO
Outperform
Oppenheimer calls Mustang Bio 'overlooked,' starts at Outperform
Oppenheimer analyst Mark Breidenbach last night initiated Mustang Bio with an Outperform rating and $18 price target. The analyst views the company an "emerging but overlooked contender" in the engineered T-cell therapies space. Mustang has in-licensed several promising CAR-Ts for solid and liquid tumors, Breidenbach told investors in a research note. He believes the company's MB-102 CAR-T has shown best-in-class efficacy and safety in acute myeloid leukemia.
FBIO Fortress Biotech
$2.70

-0.105 (-3.75%)

02/28/18
02/28/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dell Technologies (DVMT) initiated with a Buy at Deutsche Bank and an Outperform at Wells Fargo. 2. Procter & Gamble (PG) initiated with a Sell at Berenberg. 3. Surmodics (SRDX) initiated with a Buy at Needham. 4. Fortress Biotech (FBIO) initiated with a Buy at B. Riley FBR. 5. Madrigal Pharmaceuticals (MDGL) initiated with an Outperform at Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/27/18
HCWC
03/27/18
NO CHANGE
Target $11
HCWC
Buy
H.C. Wainwright sees positive Phase 3 data for Fortress Biotech
H.C. Wainwright analyst Joseph Pantginis says additional Phase 1b analysis shows Fortress Biotech's CAEL-101 administration improves heart function. Caelum, a Fortress subsidiary, presented a new analysis of data from the Phase 1b trial of CAEL-101 for the treatment of amyloid light chain amyloidosis, the analyst writes in a research note. He believes these data should translate to a positive Phase 3, which he thinks should begin this year. The analyst stays bullish on Fortress Biotech with a Buy rating and $11 price target.
05/21/18
HCWC
05/21/18
NO CHANGE
Target $11
HCWC
Buy
Fortress subsidiary met endpoint in Phase 3 trial, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis says Fortress Biotech (FBIO) subsidiary Avenue Therapeutics (ATXI) announced this morning that its pivotal Phase 3 trial of IV tramadol achieved the primary endpoint in patients with moderate to moderately severe postoperative pain following bunionectomy surgery as well as important secondary endpoints. IV tramadol has the potential to be the first Schedule IV opioid in the U.S., and could be an important addition to pain treatments, Pantginis tells investors in a research note. The analyst currently projects $175M in peak sales, which he believes could be conservative based on the drug's profile. He reiterates a Buy rating on Fortress Biotech with an $11 price target.
05/21/18
JMPS
05/21/18
NO CHANGE
JMPS
Fortress subsidiary's positive Phase III data encouraging, says JMP Securities
JMP Securities analyst Konstantinos Aprilakis believes Fortress Biotech subsidiary Avenue Therapeutics' positive top-line Phase III data for intravenous tramadol is encouraging, and further believes that IV tramadol may provide a bridge to oral tramadol and has the potential to displace Schedule II narcotics altogether for many patients. Aprilakis reiterated a Market Outperform rating and $11 price target on Fortress Biotech shares.

TODAY'S FREE FLY STORIES

NVS

Novartis

$87.04

2.58 (3.05%)

12:47
05/24/19
05/24
12:47
05/24/19
12:47
Hot Stocks
Novartis says wholesale acquisition cost of Zolgensma $2.125M »

AveXis, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

TIVO

TiVo

$6.87

0.04 (0.59%)

12:45
05/24/19
05/24
12:45
05/24/19
12:45
Options
TiVo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

12:45
05/24/19
05/24
12:45
05/24/19
12:45
General news
Breaking General news story  »

Week of 5/24 Baker-Hughes…

VWAGY

Volkswagen

$0.00

(0.00%)

12:42
05/24/19
05/24
12:42
05/24/19
12:42
Periodicals
Appeals court rules in favor of Volkswagen diesel car owners, Reuters reports »

A German appeals court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$56.30

0.85 (1.53%)

, WCG

WellCare

$267.57

-6.89 (-2.51%)

12:42
05/24/19
05/24
12:42
05/24/19
12:42
Periodicals
Third Point confirms Centene stake to CNBC, says WellCare deal in best interest »

CNBC tweeted: "Third…

CNC

Centene

$56.30

0.85 (1.53%)

WCG

WellCare

$267.57

-6.89 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

SPY

SPDR S&P 500 ETF Trust

$282.86

0.67 (0.24%)

, IVV

iShares Core S&P 500

$284.83

0.69 (0.24%)

12:40
05/24/19
05/24
12:40
05/24/19
12:40
Technical Analysis
On The Fly: ETF fund flow highlights »

Flows for the past week…

SPY

SPDR S&P 500 ETF Trust

$282.86

0.67 (0.24%)

IVV

iShares Core S&P 500

$284.83

0.69 (0.24%)

XLK

Technology Select Sector SPDR

$73.62

0.33 (0.45%)

SMH

Market Vectors Semiconductor

$100.37

0.23 (0.23%)

SOXX

iShares PHLX Semiconductor ETF

$180.13

0.06 (0.03%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$119.60

0.14 (0.12%)

EEM

iShares MSCI Emerging Markets ETF

$40.00

0.08 (0.20%)

XLU

Utilities SPDR

$59.99

0.07 (0.12%)

XLV

Health Care Select Sector SPDR

$89.56

0.17 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$126.65

0.46 (0.36%)

, CCOEY

Capcom

$0.00

(0.00%)

12:37
05/24/19
05/24
12:37
05/24/19
12:37
Hot Stocks
Microsoft says Project xCloud can stream more than 3,500 games »

Kareem Choudhry,…

MSFT

Microsoft

$126.65

0.46 (0.36%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

NVS

Novartis

$86.93

2.47 (2.92%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33
Hot Stocks
Novartis announces FDA approval for Zolgensma »

AveXis, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

CNC

Centene

$55.37

-0.08 (-0.14%)

, WCG

WellCare

$273.18

-1.28 (-0.47%)

12:33
05/24/19
05/24
12:33
05/24/19
12:33
Periodicals
Third Point thinks Centene should consider sale before buying WellCare, WSJ says »

Daniel Loeb's Third…

CNC

Centene

$55.37

-0.08 (-0.14%)

WCG

WellCare

$273.18

-1.28 (-0.47%)

HUM

Humana

$262.97

3.1 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 05

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

  • 13

    Nov

NVS

Novartis

$86.95

2.49 (2.95%)

12:31
05/24/19
05/24
12:31
05/24/19
12:31
Hot Stocks
Breaking Hot Stocks news story on Novartis »

Novartis announces FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

KNX

Knight-Swift

$29.75

-0.65 (-2.14%)

12:30
05/24/19
05/24
12:30
05/24/19
12:30
Options
Volatility play opened in Knight Transportation »

Volatility play opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 13

    Nov

WCG

WellCare

$273.55

-0.91 (-0.33%)

, CNC

Centene

$55.41

-0.04 (-0.07%)

12:27
05/24/19
05/24
12:27
05/24/19
12:27
Periodicals
Breaking Periodicals news story on WellCare, Centene »

Activist Third Point has…

WCG

WellCare

$273.55

-0.91 (-0.33%)

CNC

Centene

$55.41

-0.04 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

WCG

WellCare

$273.55

-0.91 (-0.33%)

, CNC

Centene

$55.41

-0.04 (-0.07%)

12:26
05/24/19
05/24
12:26
05/24/19
12:26
Periodicals
Breaking Periodicals news story on WellCare, Centene »

Third Point thinks…

WCG

WellCare

$273.55

-0.91 (-0.33%)

CNC

Centene

$55.41

-0.04 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 23

    Jul

FLEX

Flex

$9.39

-0.08 (-0.84%)

12:25
05/24/19
05/24
12:25
05/24/19
12:25
Periodicals
Huawei phone assembler Flex stops production at China factory, NAR says »

Flex, Huawei's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$357.37

6.8 (1.94%)

12:23
05/24/19
05/24
12:23
05/24/19
12:23
Periodicals
SEC probing Boeing disclosures on grounded 737 Max, Bloomberg reports »

The SEC is investigating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

SNA

Snap-On

$157.57

0.25 (0.16%)

12:20
05/24/19
05/24
12:20
05/24/19
12:20
Options
Bullish call spread in Snap On will create its biggest open interest »

Bullish call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
05/24/19
05/24
12:17
05/24/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
05/24/19
05/24
12:16
05/24/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$358.20

7.63 (2.18%)

, SMI

SMIC

$5.18

-0.315 (-5.74%)

12:13
05/24/19
05/24
12:13
05/24/19
12:13
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are finishing out…

BA

Boeing

$358.20

7.63 (2.18%)

SMI

SMIC

$5.18

-0.315 (-5.74%)

FL

Foot Locker

$44.14

-8.705 (-16.47%)

HPQ

HP Inc.

$20.06

0.865 (4.51%)

HPE

HP Enterprise

$14.64

0.31 (2.16%)

TSS

TSYS

$110.03

10.42 (10.46%)

GPN

Global Payments

$152.60

4.63 (3.13%)

HIBB

Hibbett Sports

$24.25

4.405 (22.20%)

DVAX

Dynavax

$5.33

-1.03 (-16.20%)

SPLK

Splunk

$117.39

-11.29 (-8.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 09

    Jul

  • 09

    Jul

  • 13

    Nov

ACHC

Acadia

$32.58

0.35 (1.09%)

12:13
05/24/19
05/24
12:13
05/24/19
12:13
Conference/Events
Acadia to hold a strategic update conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

BA

Boeing

$357.94

7.365 (2.10%)

12:12
05/24/19
05/24
12:12
05/24/19
12:12
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing off highs, still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

BA

Boeing

$357.77

7.2 (2.05%)

12:12
05/24/19
05/24
12:12
05/24/19
12:12
Periodicals
Breaking Periodicals news story on Boeing »

SEC probing Boeing over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

SWKS

Skyworks

$69.32

0.77 (1.12%)

12:10
05/24/19
05/24
12:10
05/24/19
12:10
Options
Call buyer loading up on Skyworks July 70s »

Call buyer loading up on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

TSS

TSYS

$109.69

10.08 (10.12%)

, GPN

Global Payments

$152.48

4.51 (3.05%)

12:09
05/24/19
05/24
12:09
05/24/19
12:09
Periodicals
Global Payments near deal to acquire TSYS for $20B in stock, CNBC reports »

Global Payments (GPN) is…

TSS

TSYS

$109.69

10.08 (10.12%)

GPN

Global Payments

$152.48

4.51 (3.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 05

    Jun

  • 13

    Nov

ESV

Ensco Rowan

$8.56

-0.285 (-3.22%)

12:05
05/24/19
05/24
12:05
05/24/19
12:05
Options
Ensco call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.